Prof. Dr. med. Hartmut Link
机构: Sprechstunde Innere Medizin, Hämatologie, internistische Onkologie
每年引用次数
引用次数
引用: 20,418
H-指数: 64
I10-指数 : 171
出版物: 734
Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT.
A Schwardt , H Link , G Ehninger , F Wingen
Bone Marrow Transplantation 11 ( 5) 403 -406
32
1993
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
H Wandt , M C Sauerland , H Gudat , D Haase
Leukemia 10 ( 8) 1288 -1295
171
1996
Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Infectious Disease Working Party of the European Group for Bone Marrow Transplantation.
M Michallet , P Ljungman , H Link , Alberto Bosi
Bone Marrow Transplantation 13 ( 2) 209 -212
64
1994
Antimicrobial prophylaxis and therapy in neutropenia
H Link
Mycoses 21 -32
3
2003
Standards for specialist units undertaking blood and marrow stem cell transplants--recommendations from the EBMT. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation (EBMT).
H Link , J Goldman , A Gratwohl , N Schmitz
Bone Marrow Transplantation 16 ( 6) 733 -736
8
1995
Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
J Casper , I Südmeier , H Link , H J Tischler
Bone Marrow Transplantation 14 ( 5) 791 -797
23
1994
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
N Schmitz , P Dreger , D.C Linch , A.H Goldstone
The Lancet 347 ( 8998) 353 -357
560
1996
Therapeutic Drug Monitoring and in Vitro Activity of the Glycopeptide Antibiotic Teicoplanin
D Petersen , A Steffen , W Bautsch , S Ziesing
Therapeutic Drug Monitoring 15 ( 2) 141
2
1993
Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
T J Smith , B E Hillner , N Schmitz , D C Linch
Journal of Clinical Oncology 15 ( 1) 5 -10
131
1997
Lung function changes after allogenic bone marrow transplantation.
H Link , U Reinhard , M Blaurock , P Ostendorf
Thorax 41 ( 7) 508 -512
31
1986
Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial
G Huebner , , H Link , C H Kohne
British Journal of Cancer 100 ( 1) 44 -49
49
2009
A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
H Link , MA Boogaerts , AA Fauser , S Slavin
Blood 84 ( 10) 3327 -3335
74
1994
A Controlled Trial of Recombinant Human Granulocyte-macrophage Colony-stimulating Factor After Total-body Irradiation, High-dose Chemotherapy, and Autologous Bone-marrow Transplantation for Acute Lymphoblastic-leukemia Or Malignant-lymphoma
H Link , MA Boogaerts , AM Carella , A Ferrant
Blood 80 ( 9) 2188 -2195
85
1992
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
P Fenaux , MC Le Deley , S Castaigne , E Archimbaud
Blood 82 ( 11) 3241 -3249
461
1993
Immune thyroiditis after transplantation of allogeneic CD34 + selected peripheral blood cells
M Karthaus , T Gabrysiak , G Brabant , A Prahst
Bone Marrow Transplantation 20 ( 8) 697 -699
37
1997
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML
T Fischer , A Neubauer , J Mohm , D Huhn
Bone Marrow Transplantation 21 ( 10) 1029 -1036
19
1998
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
C Müller-Tidow , P Tschanter , C Röllig , C Thiede
Leukemia 30 ( 3) 555 -561
38
2016
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann , , M Lauseker , S Saußele
Leukemia 31 ( 11) 2398 -2406
239
2017
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
H Einsele , H Bertz , J Beyer , MG Kiehl
Deutsche Medizinische Wochenschrift 126 ( 45) 1278 -1284
12
2001
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline-based chemotherapy : the European APL group experience (APL 91 and APL 93 trials)
C Kelaidi , , L Ades , S Chevret
Leukemia 20 ( 5) 905 -907
15
2006